# STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study

Study · id `cardio:ct-nct03777631` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03777631](<https://clinicaltrials.gov/study/NCT03777631>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03777631

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 251 participants.

## Technical summary

Registry record NCT03777631. Randomized; no masking; primary purpose prevention. Start 2018-04-01 (actual); primary completion 2026-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT03777631, source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)
- Started: 2018-04-01 (actual) (ClinicalTrials.gov record NCT03777631, source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)
- Primary completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT03777631, source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)
- Completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT03777631, source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT03777631, source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03777631-2023-11-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study
- Acronym: STABLED
- Condition: Ischemic Stroke
- Condition: Atrial Fibrillation Non-Rheumatic
- Intervention (Procedure): Catheter ablation
- Lead sponsor: Nippon Medical School
- Lead sponsor class: OTHER
- Collaborator: Daiichi Sankyo Co., Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Nippon Medical School (`cardio:org-nippon-medical-school`)
- Registry lists this organization as a collaborator: Daiichi Sankyo Co., Ltd. (`cardio:org-daiichi-sankyo-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial (`cardio:pubmed-41770549`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 187097141d63743d1f259a1bf056eea0de39616564665fa4acd02edf19f60eb0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
